Cooley
Yiming Liu
- Deals
- 2
- Latest
- Sep 2026
- Most deals in
- Biotech
Firm
- Cooley Law firm · 2026 · 2 deals
Often works with
- Rama Padmanabhan 1 deal together
- Marya Postner 1 deal together
- Jenny Ge 1 deal together
- Zack Gong 1 deal together
- Michael Yu 1 deal together
- Hilda Li 1 deal together
- Ying Liu 1 deal together
- Xinwei Li 1 deal together
Deals
US deals dated after 30 September 2026 are still being collected.
Columns
| Sep 2026 | trispecific T cell-engager (TCE) asset | Chimagen Biosciences | GSK | Asset sale | Legal adviser to Chimagen Biosciences (seller) | Announced | 750.0 | Biotech+2 | GSK acquisition of trispecific T cell-engager (TCE) asset |
| May 2026 | IMPACT Therapeutics | – | – | IPO | Legal adviser to the issuer | Listed | – | Biotech+2 | IMPACT Therapeutics IPO |
Deals where Yiming Liu is named on the firm's deal team, by the firm or the press.